Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Inactivation or attenuation; producing viral subunits
Patent
1997-04-08
1999-04-06
Smith, Lynette F.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Inactivation or attenuation; producing viral subunits
4352351, 435236, C12N 706, C12N 704, C12N 700
Patent
active
058917055
ABSTRACT:
The present invention concerns a method for inactivating a virus for use in e.g. a vaccine, by treating the virus with an ethyleneimine at a pH of less than 7.0, and methods of treatment with the inactivated virus.
REFERENCES:
patent: 3492289 (1970-01-01), Symm et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 5009951 (1991-04-01), Bass et al.
patent: 5055485 (1991-10-01), Geacintov et al.
patent: 5120649 (1992-06-01), Horowitz et al.
patent: 5232844 (1993-08-01), Horowitz et al.
patent: 5374424 (1994-12-01), Kelsey et al.
Bahnemann, Hans G., Vaccine, vol. 8, "Inactivation of Viral Antigens for Vaccine Preparation with Particular Reference to the Application of Binary Ethylenimine," pp. 299-303 (Aug. 1990).
Budowsky, Edward I. et al., Vaccine Research, vol. 5, No. 1, "Principles of Selective Inactivation of the Viral Genome: Dependence of the Rate of Viral RNA Modification on the Number of Protonizable Groups in Ethyleneimine Oligomers," pp. 29-39 (1996).
Budowsky, Edward I. et al., Vaccine, vol. 9, "Principles of Selective Inactivation of Viral Genome. V. Rational Selection of Conditions for Inactivation of the Viral Suspension Infectivity to a Given Extent by the Action of .beta.-propiolactone," pp. 319-325 (May 91).
Dermer, O. C. et al., Academic Press, Ethylenimine and Other Aziridines, "Ring-Destroying Reactions of Aziridines," pp. 248-285 (1969).
Earley, J.E., et al., Contribution from the Metcalf Chemical Laboratories of Brown University, vol. 80, "Reactions of Ethylenimines. IX. The Mechanisms of Ring Openings of Ethylenimines in Acidic Aqueous Solutions," pp. 3458-3462 (Jan. 11, 1958).
Kostyanovskii, R.G., et al., Bulletin of the Academy of Sciences of the USSR, vol. 37, No. 11, Part 2, "Oligomers of Aziridines and N-.beta.-Aziridinoethylamides," pp. 2315-2325 (1989).
Kochetkov, N.K. et al., Organic Chemistry of Nucleic Acids, Part A, Plenum Press, "Structure of the Nucleic Acids," pp. 48-55 (1971).
Race, Esther et al., Vaccine, vol. 13, No. 1, "An Experimental Chemically Inactivated HIV-1 Vaccines Induces Antibodies that Neutralize Homologous and Heterologous Viruses," pp. 54-60 (1995).
Bahnemann, H.G., "Inactivation of Viruses in Serum with Binary Ethyleneimine", Journal of Clinical Microbiology, vol. 3, No. 2, pp. 209-210 (1975).
Budowsky et al., "Inactivation of the phage MS2 infectivity by the action of ethyleneimines," Biorg. Khim. 11:989-991 (1985) (in Russian). English Translation provided, 3 pages.
King, "Evaluation of Different Methods of Inactivation of Newcastle Disease Virus and Avian Influenza Virus in Egg Fluids and Serum," Avian Diseases 35:505-514 (1991).
Prodouz et al., "Inhibition of Merocyainine 540-mediated Photosensitization of Platelets and Viruses," Transfusion 31:415-422 (1991).
Tanirbergenov, T.B. et al., "Regularities of mutagenic and toxic effects of ethyleneimine and its oligomers. A comparative study in the automated system SOS-chromotest and in standard bacterial test systems," Genetika 24:763 (1988) (in Russian). English translation provided, 5 pages.
Van Etten, R.L. and Dolhum, J.J., "Effects of Hydrogen-Bond Formation by Phenols on the Conformational Equilibrium of trans-1,2-Dimethyl-3-isopropylaziridine," J. Org. Chem. 33:3904-3907 (1968).
Wagner et al., "Approaches to the Reduction of Viral Infectivity in Cellular Blood Components and Single Donor Plasma," Transfusion Med. Rev. V:18-32 (1991).
Budowsky, U.S. Patent Application Serial No.: 08/521,245, filed Aug. 29, 1995, entitled: "Methods and Compositions for the Selective Modification of Nucleic Acids".
Budowsky, U.S. Patent Application Serial No.: 08/705,045, filed Aug. 29, 1996, entitled: "Methods and Compositions for the Selective Modification of Nucleic Acids".
Twomey, et al. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines, Vaccine, vol. 13, No. 16, pp. 1603-1610, 1995.
Ackerman Samuel K.
Budowsky Edward I.
Brumback Brenda G.
Pentose Pharmaceuticals, Inc.
Smith Lynette F.
LandOfFree
Method for inactivating a virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inactivating a virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inactivating a virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1370587